Advertisement
Advertisement

Medicenna Therapeutics expects cash to fund operations through 3Q24

As of June 30, 2023, cash, cash equivalents and marketable securities were $29.6 million, compared to $33.6 million on March 31, 2023.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on MDNA:

Disclaimer & DisclosureReport an Issue

1